[
  {
    "ts": null,
    "headline": "Sanofi Plans to Change Hospital Drug-Discount Program",
    "summary": "The drugmaker looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients.",
    "url": "https://finnhub.io/api/news?id=6de1763df2f3393cce0cf4a3e829352d510a02110eb9378a12ba2a3b9e367e28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732293540,
      "headline": "Sanofi Plans to Change Hospital Drug-Discount Program",
      "id": 131569331,
      "image": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The drugmaker looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients.",
      "url": "https://finnhub.io/api/news?id=6de1763df2f3393cce0cf4a3e829352d510a02110eb9378a12ba2a3b9e367e28"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=5190a5d5d0e0f1db7868a17c2be3261957314e47ec9893405f2d16656e7b569e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732293180,
      "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "id": 131598539,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=5190a5d5d0e0f1db7868a17c2be3261957314e47ec9893405f2d16656e7b569e"
    }
  },
  {
    "ts": null,
    "headline": "RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?",
    "summary": "RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?",
    "url": "https://finnhub.io/api/news?id=3a22a90214c3c17f3eab9e414ce55dd3828e9c220a3562cd7032c994b9f3a5e4",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732292245,
      "headline": "RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?",
      "id": 131598519,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?",
      "url": "https://finnhub.io/api/news?id=3a22a90214c3c17f3eab9e414ce55dd3828e9c220a3562cd7032c994b9f3a5e4"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie: Upgrading To 'Strong Buy' After Pullback",
    "summary": "AbbVieâs high dividend yield and leadership with Skyrizi and Rinvoq make it a top pick. Learn why ABBV stock is a strong buy for long-term growth.",
    "url": "https://finnhub.io/api/news?id=0df10e1bcbeba0158dcbfaf1a9f8e50e0b4cf1c080a74bf9c7b958beb9447381",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732288243,
      "headline": "AbbVie: Upgrading To 'Strong Buy' After Pullback",
      "id": 131571049,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153992734/image_2153992734.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "AbbVieâs high dividend yield and leadership with Skyrizi and Rinvoq make it a top pick. Learn why ABBV stock is a strong buy for long-term growth.",
      "url": "https://finnhub.io/api/news?id=0df10e1bcbeba0158dcbfaf1a9f8e50e0b4cf1c080a74bf9c7b958beb9447381"
    }
  },
  {
    "ts": null,
    "headline": "VKTX Stock Loses Over $1B in a Month: How to Play the Stock?",
    "summary": "The plunge in Viking Therapeutics' share price can be attributed to the rising competition in the sector to secure a position in the booming obesity market.",
    "url": "https://finnhub.io/api/news?id=c9fe72db52be5131b3e9d492eca54696d63bb7d0b48790e2d861248242bffc99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732285080,
      "headline": "VKTX Stock Loses Over $1B in a Month: How to Play the Stock?",
      "id": 131567362,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The plunge in Viking Therapeutics' share price can be attributed to the rising competition in the sector to secure a position in the booming obesity market.",
      "url": "https://finnhub.io/api/news?id=c9fe72db52be5131b3e9d492eca54696d63bb7d0b48790e2d861248242bffc99"
    }
  },
  {
    "ts": null,
    "headline": "Investing in Pharma Stocks? Check These 3 Things First",
    "summary": "The world of pharmacenutical stocks has a lot to offer investors.  With their resilience in the face of economic issues and frequently in the face of market fluctuations as well, pharma stocks can serve as an anchor for your portfolio.  Pharma companies use and generate a lot of capital.",
    "url": "https://finnhub.io/api/news?id=3b33cbde8d833d20792984f5e2daae42e387545522363b6b2ce766e2d257baf7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732284900,
      "headline": "Investing in Pharma Stocks? Check These 3 Things First",
      "id": 131564499,
      "image": "https://g.foolcdn.com/editorial/images/798355/two-older-investors-smile-while-looking-at-papers.jpg",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The world of pharmacenutical stocks has a lot to offer investors.  With their resilience in the face of economic issues and frequently in the face of market fluctuations as well, pharma stocks can serve as an anchor for your portfolio.  Pharma companies use and generate a lot of capital.",
      "url": "https://finnhub.io/api/news?id=3b33cbde8d833d20792984f5e2daae42e387545522363b6b2ce766e2d257baf7"
    }
  },
  {
    "ts": null,
    "headline": "Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?",
    "summary": "Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.",
    "url": "https://finnhub.io/api/news?id=6a857b66fc02552d614a8a872c123973ef9cfa1648d89065e358370f36dc547a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732280425,
      "headline": "Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?",
      "id": 131563568,
      "image": "https://media.zenfs.com/en/ibd.com/b61eb215ccb53624274765e4beee9de9",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.",
      "url": "https://finnhub.io/api/news?id=6a857b66fc02552d614a8a872c123973ef9cfa1648d89065e358370f36dc547a"
    }
  },
  {
    "ts": null,
    "headline": "Nvidia's Big Buildup, Then A Shrug",
    "summary": "Nvidia earnings - big buildup, then a shrug. How long can Bitcoin's run can last?",
    "url": "https://finnhub.io/api/news?id=c704dcb89297fafca5d9d2b12fda2a8fd625f16701568903a3fafa65322901da",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732279800,
      "headline": "Nvidia's Big Buildup, Then A Shrug",
      "id": 131568219,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1006384150/image_1006384150.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Nvidia earnings - big buildup, then a shrug. How long can Bitcoin's run can last?",
      "url": "https://finnhub.io/api/news?id=c704dcb89297fafca5d9d2b12fda2a8fd625f16701568903a3fafa65322901da"
    }
  },
  {
    "ts": null,
    "headline": "Sanofi plans to change hospital drug-discount program, WSJ reports",
    "summary": "French drugmaker Sanofi plans to change its policy on how it gives discounts to certain U.S. hospitals that serve low-income and uninsured patients, the Wall Street Journal reported on Friday. ...",
    "url": "https://finnhub.io/api/news?id=1b06f005b95a22f3964c890c71547fb46eef5c6be64cb8f34715a8e04c15efc1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732278729,
      "headline": "Sanofi plans to change hospital drug-discount program, WSJ reports",
      "id": 131567940,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "French drugmaker Sanofi plans to change its policy on how it gives discounts to certain U.S. hospitals that serve low-income and uninsured patients, the Wall Street Journal reported on Friday. ...",
      "url": "https://finnhub.io/api/news?id=1b06f005b95a22f3964c890c71547fb46eef5c6be64cb8f34715a8e04c15efc1"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock",
    "summary": "We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this piece, we will look at where Eli Lilly and Company (NYSE:LLY) ranks on the list. With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future […]",
    "url": "https://finnhub.io/api/news?id=96c94e00526ef336b528b0db66f51ce47b9ba5457a268ce89c2c5c9a8a479a41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732272350,
      "headline": "Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock",
      "id": 131562741,
      "image": "https://s.yimg.com/ny/api/res/1.2/ALEOMLtAm3suwcmJZDXDHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/7b67cae29a642446338abc3321276426",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this piece, we will look at where Eli Lilly and Company (NYSE:LLY) ranks on the list. With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future […]",
      "url": "https://finnhub.io/api/news?id=96c94e00526ef336b528b0db66f51ce47b9ba5457a268ce89c2c5c9a8a479a41"
    }
  },
  {
    "ts": null,
    "headline": "The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.",
    "summary": "The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.",
    "url": "https://finnhub.io/api/news?id=f5f8e00afeea7dc04f53a21320183d12a7e7515a930aa3735cabb8c209ec2301",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732268040,
      "headline": "The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.",
      "id": 131598540,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.",
      "url": "https://finnhub.io/api/news?id=f5f8e00afeea7dc04f53a21320183d12a7e7515a930aa3735cabb8c209ec2301"
    }
  }
]